🇺🇸 FDA
Patent

US 9994852

Oligonucleotide compositions and uses thereof

granted A61PA61P35/00A61P35/02

Quick answer

US patent 9994852 (Oligonucleotide compositions and uses thereof) held by MIRAGEN THERAPEUTICS, INC. expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MIRAGEN THERAPEUTICS, INC.
Grant date
Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P35/00, A61P35/02, A61P43/00